• Services
    • Valuation and Financial Advisory
      • Fairness Opinions
        • SPAC Fairness Opinions
      • Solvency Opinions
      • Portfolio Valuation & Fund Advisory Services
        • Complex & Illiquid Security Valuations
        • Fund Valuation Policies & Procedures
        • AIFMD & The Professional Guarantee
        • Investment Management Advisory
      • Financial Reporting & Tax Compliance
      • Intellectual Property
      • Consulting Services
      • Family Office Services
    • Investment Banking
      • Mergers & Acquisitions
      • Corporate Financial Services
      • Investment Banking – Industry Expertise
  • Team
  • Experience
    • Fairness Opinion Transactions
    • Solvency Opinion Transactions
    • Valuation Opinion Transactions
    • Financial Advisory Transactions
  • Who We Serve
    • Private Equity & SBIC Funds
    • Hedge Funds
    • ’40 Act Funds
    • Corporations
    • Business Development Companies
  • Industries
  • News & Articles
  • Services
    • Valuation and Financial Advisory
      • Fairness Opinions
        • SPAC Fairness Opinions
      • Solvency Opinions
      • Portfolio Valuation & Fund Advisory Services
        • Complex & Illiquid Security Valuations
        • Fund Valuation Policies & Procedures
        • AIFMD & The Professional Guarantee
        • Investment Management Advisory
      • Financial Reporting & Tax Compliance
      • Intellectual Property
      • Consulting Services
      • Family Office Services
    • Investment Banking
      • Mergers & Acquisitions
      • Corporate Financial Services
      • Investment Banking – Industry Expertise
  • Team
  • Experience
    • Fairness Opinion Transactions
    • Solvency Opinion Transactions
    • Valuation Opinion Transactions
    • Financial Advisory Transactions
  • Who We Serve
    • Private Equity & SBIC Funds
    • Hedge Funds
    • ’40 Act Funds
    • Corporations
    • Business Development Companies
  • Industries
  • News & Articles
Contact

Q1 2023 – Cannabis

Q1 2023 - Cannabis

Share
FacebookTwitterLinkedInPinterestStumbleuponEmail
PrevQ1 2023 – Cannabis

Recent Posts

  • The Growing Demand for MedSpa Businesses: Is Now the Time to Sell?
  • Goodwill Impairment (ASC 350): A Clear and Concise Guide
  • U.S. Micro Middle Market Report – 2H 2024
  • Houlihan Capital advised Cleveland Cement Contractors on the sale of certain assets to Baker Construction
  • Michael Norton discusses Valuation Trends, Buyer-Seller Dynamics and Advice for Sell-Side Businesses with Levenfeld Pearlstein

Archives

Categories

Main Office

200 W. Madison Street, Suite 2150
Chicago, IL 60606

Branch Office

2400 Superior Ave E, 1st Floor
Cleveland, OH 44114

Inquiries

info@houlihancapital.com
(312) 450-8600

© 2025. All Rights Reserved | Powered by CTS

Privacy Policy | Sitemap
Member of FINRA | Member of SIPC
Careers

SiteLock